RecruitingPhase 4

The Effect of PAP on ISSHL Comorbided With OSA

China102 participantsStarted 2019-11-01

Plain-language summary

This clinical randomized controlled study is to explore the effect of positive airway pressure(PAP) on patients in Beijing Tsinghua Changgung Hospital diagnosed with both idiopathic sudden sensorineural hearing loss comorbided(ISSHL) and obstructive sleep apnea(OSA) between Dec. 2019 to Dec. 2029.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. aged \>= 18 and \<= 70,
✓. diagnosed with OSA by full-night in-lab or home-stay PSG according to AASM 2012 criteria, and AHI \> 15/h,
✓. diagnosed with ISSHL by AAO-HNS 2019 criteria,
✓. ISSHL onset within 1 week.

Exclusion criteria

✕. sudden hearing loss with certain causes,
✕. with severe comorbid diseases,
✕. pregnant or breast-feeding women,
✕. AHI \<= 15/h,
✕. hearing threshold recovered \> 50% when included,
✕. previously regularly treated with PAP.

What they're measuring

hearing threshold

Timeframe: 3 months after onset of ISSHL

Trial details

NCT IDNCT04192656

SponsorBeijing Tsinghua Chang Gung Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-12

Contact for this trial

Jingying Ye, MD

+86-13701396970 yejingying@163.vip.com

View on ClinicalTrials.gov More Sudden Hearing Loss trials